News und Analysen
BALYO gibt die Verlängerung seines Partnerschaftsvertrags mit der KION Group um weitere vier Jahre bekannt
BALYO (FR0013258399, Tickersymbol: BALYO, PEA-PME-qualifiziert), Technologieführer im Bereich Konzeption und Entwicklung innovativer Roboterlösungen für Flurförderzeuge, gibt die Verlängerung
BALYO Announces the Renewal of Its Cooperation Agreement With the KION Group for the Next 4 Years
Regulatory News:
BALYO (FR0013258399, Ticker: BALYO, eligible for PEA-PME savings schemes), a technological leader in the design and development of innovative robotic solutions for material
The GAUSSIN Group and Its European Distributor BLYYD Announce That the ATM 38T FULL ELEC Has Passed the One Million Kilometer Mark
GAUSSIN (EURONEXT GROWTH ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, announces that its ATM 38T FULL ELEC vehicle, dedicated to logistics, has
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
Transgene: Q1 2022 Financial Position and Business Update
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update for the
Voyageurs du Monde acquires 'Eurofun Group', the European leader in bike travel
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2021
Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS’MEETING ON MAY 5TH, 2022
Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2021
NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
Poxel Announces Availability of Its 2021 Universal Registration Document
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
New Project in Latin America for NHOA: 30MWh to Support the Electrical Grid in Peru
Regulatory News:
NHOA (NHOA.PA, formerly Engie EPS) is pleased to announce the award of a turn-key 30MWh energy storage system for ENGIE Energía Perú in Chilca, the core of Peruvian power
ESI Group stellt „Inspector"-Software auf Open-Source-Basis in Zusammenarbeit mit ENSAM bereit
ESI Group (ISIN Code: FR0004110310, Mnemo: ESI), ein weltweiter Softwarepartner der Industrie für Simulation und virtuelles Prototyping, gab heute die Veröffentlichung der Open-Source-Version
ESI Group, in Collaboration With ENSAM, Deploys in Open Source Its "Inspector" Software
Regulatory News:
ESI Group (ISIN Code: FR0004110310, Mnemo: ESI), a global simulation and virtual prototyping software partner for industry, announces the open-source release of its Inspector
New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for
DGAP-News: Abivax publishes Universal Registration Document 2022 'Document d'Enregistrement Universel'
Axway Software: Q1 2022 Revenue of €66.9 Million, Above Forecasts
Regulatory News:
In Q1 2022, Axway (Euronext: AXW.PA) (Paris:AXW) made a good start to the year by continuing to accelerate its move towards a business model based primarily on subscription
Freelance.com: Sharp growth in results for the 2021 financial year
Poxel Announces Its Participation in Upcoming Scientific Conferences
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
PRESS RELEASE BY KAUFMAN & BROAD FOLLOWING THE CROSSING BY PROMOGIM OF THE 20% THRESHOLDS OF THE SHARE CAPITAL AND VOTING RIGHTS OF THE COMPANY
Mexikanisches Telekommunikationsunternehmen Megacable wählt Verimatrix Streamkeeper und XTD-Lösungen zur weiteren Stärkung der Sicherheit
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, teilte heute mit, dass Megacable, eines der größten
Mexico’s Megacable Selects Verimatrix Streamkeeper and XTD Products To Further Strengthen Security
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Megacable, one of Mexico’s
NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3
Regulatory News:
NANOBOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for
Verimatrix kündigt Teilnahme an drei NAB Show-Sitzungen vom 24. bis 26. April in Las Vegas an
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, hat heute die folgenden NAB Show-Sitzungen im Las Vegas